Evaluation of locoregional invasiveness of early lung adenocarcinoma manifesting as ground-glass nodules via [Ga]Ga-FAPI-46 PET/CT imaging.

PURPOSE

Accurate differentiation of the histologic invasiveness of early-stage lung adenocarcinoma is crucial for determining surgical strategies. This study aimed to investigate the potential of [Ga]Ga-FAPI-46 PET/CT in assessing the invasiveness of early lung adenocarcinoma presenting as ground-glass nodules (GGNs) and identifying imaging features with strong predictive potential.

METHODS

This prospective study (NCT04588064) was conducted between July 2020 and July 2022, focusing on GGNs that were confirmed postoperatively to be either invasive adenocarcinoma (IAC), minimally invasive adenocarcinoma (MIA), or precursor glandular lesions (PGL). A total of 45 patients with 53 pulmonary GGNs were included in the study: 19 patients with GGNs associated with PGL-MIA and 34 with IAC. Lung nodules were segmented using the Segment Anything Model in Medical Images (MedSAM) and the PET Tumor Segmentation Extension. Clinical characteristics, along with conventional and high-throughput radiomics features from High-resolution CT (HRCT) and PET scans, were analysed. The predictive performance of these features in differentiating between PGL or MIA (PGL-MIA) and IAC was assessed using 5-fold cross-validation across six machine learning algorithms. Model validation was performed on an independent external test set (n = 11). The Chi-squared, Fisher's exact, and DeLong tests were employed to compare the performance of the models.

RESULTS

The maximum standardised uptake value (SUVmax) derived from [Ga]Ga-FAPI-46 PET was identified as an independent predictor of IAC. A cut-off value of 1.82 yielded a sensitivity of 94% (32/34), specificity of 84% (16/19), and an overall accuracy of 91% (48/53) in the training set, while achieving 100% (12/12) accuracy in the external test set. Radiomics-based classification further improved diagnostic performance, achieving a sensitivity of 97% (33/34), specificity of 89% (17/19), accuracy of 94% (50/53), and an area under the receiver operating characteristic curve (AUC) of 0.97 [95% CI: 0.93-1.00]. Compared with the CT-based radiomics model and the PET-based model, the combined PET/CT radiomics model did not show significant improvement in predictive performance. The key predictive feature was [Ga]Ga-FAPI-46 PET log-sigma-7-mm-3D_firstorder_RootMeanSquared.

CONCLUSION

The SUVmax derived from [Ga]Ga-FAPI-46 PET/CT can effectively differentiate the invasiveness of early-stage lung adenocarcinoma manifesting as GGNs. Integrating high-throughput features from [Ga]Ga-FAPI-46 PET/CT images can considerably enhance classification accuracy.

CLINICAL TRIAL REGISTRATION NUMBER

NCT04588064; URL: https://clinicaltrials.gov/study/NCT04588064 .